publication . Article . 2017

MOLECULAR GENETIC ASPECTS OF HEPATOCELLULAR CARCINOMA PATHOGENESIS AND CURRENT OPTIONS OF DRUG THERAPY

Open Access
  • Published: 01 Dec 2017 Journal: Advances in molecular oncology, volume 4, pages 8-16 (issn: 2313-805X, eissn: 2413-3787, Copyright policy)
  • Publisher: Publishing House ABV Press
Abstract
Liver cancer is widespread neoplasm type that ranks second among the causes of cancer-related mortality worldwide. Hepatocellular carcinoma (HCC) is the main form of liver cancer generally detected at advanced stages in most patients. HCC development is a result of accumulation of various somatic molecular alterations. Different HCC etiology and chronic liver diseases cause numerous and heterogeneous genetic and epigenetic aberrations that determine diverse gene expression alterations in HCC. Molecular heterogeneity limits the efficacy of targeted therapy that is currently the essential approach for advanced stage HCC treatment. The present review considers the ...
Persistent Identifiers
Subjects
Medical Subject Headings: digestive system diseasesneoplasms
free text keywords: hepatocarcinoma, next-generation sequencing, gsea, snea, Epigenetics, Transcriptome, Etiology, Cancer research, Targeted therapy, medicine.medical_treatment, medicine, Somatic cell, Hepatocellular carcinoma, medicine.disease, Immunotherapy, Liver cancer, business.industry, business, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282
Any information missing or wrong?Report an Issue